S-Class
2026-10-22 08:39:46
AstraZeneca says U.S. FDA approves rare kidney disease drug
S-Class
2026-07-27 17:35:19
AstraZeneca reiterates guidance after topping Q2 profit expectations; shares up
S-Class
2026-07-27 17:01:12
AstraZeneca Q2 profit beats estimates as cancer drug sales drive growth
S-Class
2026-07-27 16:31:32
Earnings Snapshot: AstraZeneca reports Q2 earnings beat, raises interim dividend, and reaffirms FY26 guidance
S-Class
2026-07-27 16:21:47
AstraZeneca Q2 Non-GAAP EPS tops expectations by $1.36; reconfirms full-year outlook